XML 49 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Segment Information - Operations by Business Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Sales, net $ 12,001 $ 10,800 $ 22,305 $ 20,570
Gross Profit 1,330 1,048 2,549 2,053
Depreciation 66 57 132 132
Capital Expenditures 269 109 287 216
Contract Manufacturing [Member]        
Sales, net 11,756 10,358 21,608 19,763
Gross Profit 1,246 896 2,328 1,731
Depreciation 66 55 131 129
Capital Expenditures 269 109 287 202
Branded Proprietary Products [Member]        
Sales, net 60 172 138 202
Gross Profit 21 65 42 97
Depreciation 1 2
Capital Expenditures 13
Other Nutraceutical Business [Member]        
Sales, net 185 270 559 605
Gross Profit 63 87 179 225
Depreciation 1 1 1
Capital Expenditures 1
UNITED STATES        
Sales, net 10,727 9,552 19,792 17,664
UNITED STATES | Contract Manufacturing [Member]        
Sales, net 10,498 9,159 19,153 16,981
UNITED STATES | Branded Proprietary Products [Member]        
Sales, net 48 162 119 181
UNITED STATES | Other Nutraceutical Business [Member]        
Sales, net 181 231 520 502
Non-US [Member]        
Sales, net 1,274 1,248 2,513 2,906
Non-US [Member] | Contract Manufacturing [Member]        
Sales, net 1,258 1,199 2,455 2,782
Non-US [Member] | Branded Proprietary Products [Member]        
Sales, net 12 10 19 21
Non-US [Member] | Other Nutraceutical Business [Member]        
Sales, net $ 4 $ 39 $ 39 $ 103